Vanguard Group Inc Glaukos Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,873,133 shares of GKOS stock, worth $871 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,873,133
Previous 5,452,757
7.71%
Holding current value
$871 Million
Previous $645 Million
18.57%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding GKOS
# of Institutions
341Shares Held
46.8MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.19 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$324 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$290 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$243 Million0.06% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.63MShares$243 Million4.67% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $7.06B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...